MAM
MBIO icon

Meeder Asset Management’s Mustang Bio MBIO Stock Holding History

Meeder Asset Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1
Closed -$2K – 2289
2020
Q1 		$2K Hold
1
– – ﹤0.01% 2097
2019
Q4 		$3K Sell
1
-2
-67% -$4.58K ﹤0.01% 1930
2019
Q3 		$7K Hold
3
– – ﹤0.01% 1648
2019
Q2 		$8K Buy
3
+1
+50% +$2.85K ﹤0.01% 1523
2019
Q1 		$5K Sell
2
-11
-85% -$31.2K ﹤0.01% 1392
2018
Q4 		$27K Buy
13
+3
+30% +$9.12K ﹤0.01% 978
2018
Q3 		$46K Buy
10
+9
+900% +$45K ﹤0.01% 803
2018
Q2 		$7.41K Buy
+1
New +$6.32K ﹤0.01% 1178

Other funds holding MBIO

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Meeder Asset Management's MBIO Position: Q2 2020 in Review

Meeder Asset Management sold out of Mustang Bio (MBIO) in Q2 2020, closing a stake of 1 share — an estimated $2K sold.

Meeder Asset Management first reported a position in MBIO in Q2 2018 and held it in 8 quarters. The position peaked at $46K in Q3 2018. 73 funds tracked by Wall St. Rank hold MBIO as of Q2 2020.

  • Meeder Asset Management reported no remaining Mustang Bio position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 1 Mustang Bio share in Q2 2020, an estimated $2K.
  • Meeder Asset Management first reported a position in Mustang Bio in Q2 2018 and held it in 8 quarters.
  • Meeder Asset Management's Mustang Bio position peaked at $46K in Q3 2018.
  • 73 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.